美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NervGen Pharma Corp.

2.14

-0.0550-2.51%

成交量：32.30萬

成交額：69.43萬

市值：2.31億

市盈率：-3.77

高：2.19

開：2.19

低：2.11

收：2.20

52周最高：6.30

52周最低：1.58

股本：1.08億

流通股本：9,539.12萬

量比：0.74

換手率：0.34%

股息：- -

股息率：- -

每股收益(TTM):-0.5680

每股收益(LYR):-0.4448

淨資產收益率：-757.48%

總資產收益率：-37.70%

市淨率：18.65

市盈率(LYR):-4.81

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善

熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌

NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行

NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/NGEN"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","market":"US","secType":"STK","nameCN":"NervGen Pharma Corp.","latestPrice":2.14,"timestamp":1789502400000,"preClose":2.195,"halted":0,"volume":322995,"delay":0,"changeRate":-0.025056947608200326,"floatShares":95391200,"shares":108000000,"eps":-0.568,"marketStatus":"盤前交易","change":-0.055,"latestTime":"09-16 08:37:21 EDT","open":2.19,"high":2.19,"low":2.11,"amount":694278.4953885,"amplitude":0.036446,"askPrice":2.35,"askSize":600,"bidPrice":2.1,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.568,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.14,"postHourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.14,"latestTime":"19:30 EDT","volume":5614,"amount":12358.17,"timestamp":1789515005538,"change":0.07,"changeRate":0.03271,"amplitude":0.062477},"volumeRatio":0.7370108383774758,"impliedVol":0.0812,"impliedVolPercentile":0.2393},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","floatShares":95391200,"roa":"-37.70%","roe":"-757.48%","lyrEps":-0.444846,"volumeRatio":0.7370108383774758,"shares":108000000,"dividePrice":0,"high":2.19,"amplitude":0.036446,"preClose":2.195,"low":2.11,"week52Low":1.58,"pbRate":"18.65","week52High":6.3,"institutionHeld":0,"latestPrice":2.14,"committee":-0.090909,"eps":-0.568,"divideRate":0,"volume":322995,"delay":0,"ttmEps":-0.568,"open":2.19,"prevYearClose":5.6,"prevWeekClose":2.185,"prevMonthClose":2.21,"prevQuarterClose":2.06,"fiveDayClose":2.19,"twentyDayClose":1.68,"sixtyDayClose":2.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"NGEN","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2026-05-15","symbol":"NGEN","fiscalQuarterEnding":"2026/03","expectedEps":-0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.09},{"date":"2026-03-31","symbol":"NGEN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"盤前","dateTimestamp":1774929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGEN","date":"2026-09-15","current":-3.767606,"percent":0.928994,"low":-25.148356,"twenty":-17.236144,"median":-9.427324,"eighty":-6.052626,"high":-4.008234,"avg":-11.171235,"sd":5.739705,"marketCap":236012179},"quantilePoints":[{"date":"2026-01-09","current":-25.148356,"twenty":-24.98651,"median":-24.743741,"eighty":-24.500973,"marketCap":463798962.95},{"date":"2026-01-16","current":-23.484013,"twenty":-24.651705,"median":-24.262661,"eighty":-23.546305,"marketCap":432253265.53},{"date":"2026-01-23","current":-22.238177,"twenty":-24.339127,"median":-23.484013,"eighty":-22.456198,"marketCap":412101315.23},{"date":"2026-01-30","current":-17.441707,"twenty":-24.262661,"median":-22.611928,"eighty":-20.307131,"marketCap":329508465.32},{"date":"2026-02-06","current":-16.382746,"twenty":-23.795472,"median":-22.238177,"eighty":-17.908896,"marketCap":306238051.42},{"date":"2026-02-13","current":-17.441707,"twenty":-23.484013,"median":-19.886661,"eighty":-17.285978,"marketCap":327197651.85},{"date":"2026-02-20","current":-18.220355,"twenty":-23.359429,"median":-18.282647,"eighty":-17.285978,"marketCap":340388899.6},{"date":"2026-02-27","current":-17.753166,"twenty":-22.879782,"median":-18.03348,"eighty":-17.410561,"marketCap":331850071.27},{"date":"2026-03-06","current":-17.223686,"twenty":-22.51849,"median":-17.893323,"eighty":-17.27352,"marketCap":321208516.98},{"date":"2026-03-13","current":-16.382746,"twenty":-22.306698,"median":-17.753166,"eighty":-16.993207,"marketCap":307553178.63},{"date":"2026-03-20","current":-16.957011,"twenty":-22.250635,"median":-17.753166,"eighty":-16.888553,"marketCap":316207550},{"date":"2026-03-27","current":-15.785094,"twenty":-21.714925,"median":-17.597437,"eighty":-16.837477,"marketCap":291516280},{"date":"2026-04-02","current":-18.89617,"twenty":-20.942507,"median":-17.535145,"eighty":-16.702393,"marketCap":347270760},{"date":"2026-04-10","current":-10.676925,"twenty":-19.970755,"median":-17.441707,"eighty":-16.494872,"marketCap":340718966},{"date":"2026-04-17","current":-10.464421,"twenty":-19.238183,"median":-17.254832,"eighty":-16.110604,"marketCap":336672423},{"date":"2026-04-24","current":-9.863583,"twenty":-18.837636,"median":-17.005665,"eighty":-12.953446,"marketCap":318058323},{"date":"2026-05-01","current":-9.064424,"twenty":-18.587877,"median":-16.950192,"eighty":-10.62677,"marketCap":293779061},{"date":"2026-05-08","current":-9.632569,"twenty":-18.344939,"median":-16.86331,"eighty":-10.287304,"marketCap":311583853},{"date":"2026-05-15","current":-9.34654,"twenty":-18.295105,"median":-16.834362,"eighty":-10.043494,"marketCap":300253531},{"date":"2026-05-22","current":-9.812417,"twenty":-18.145605,"median":-16.66306,"eighty":-9.800918,"marketCap":297825605},{"date":"2026-05-29","current":-7.287863,"twenty":-18.008563,"median":-16.66306,"eighty":-9.72533,"marketCap":220902522},{"date":"2026-06-05","current":-7.091826,"twenty":-17.902667,"median":-16.382746,"eighty":-9.634252,"marketCap":213468303},{"date":"2026-06-12","current":-6.717699,"twenty":-17.87775,"median":-16.216296,"eighty":-9.423447,"marketCap":200723927},{"date":"2026-06-18","current":-7.855923,"twenty":-17.87775,"median":-15.872071,"eighty":-9.364073,"marketCap":232584867},{"date":"2026-06-26","current":-6.880017,"twenty":-17.753166,"median":-13.39003,"eighty":-9.064424,"marketCap":202847989},{"date":"2026-07-02","current":-7.524736,"twenty":-17.753166,"median":-10.756935,"eighty":-7.674051,"marketCap":221964554},{"date":"2026-07-10","current":-6.687968,"twenty":-17.753166,"median":-10.600843,"eighty":-7.470839,"marketCap":197537832},{"date":"2026-07-17","current":-5.950494,"twenty":-17.703333,"median":-10.394273,"eighty":-7.2635,"marketCap":177359237},{"date":"2026-07-24","current":-5.990968,"twenty":-17.616125,"median":-10.19196,"eighty":-7.15871,"marketCap":177890252},{"date":"2026-07-31","current":-5.701372,"twenty":-17.597437,"median":-10.084942,"eighty":-7.057391,"marketCap":170260212},{"date":"2026-08-07","current":-6.137986,"twenty":-17.522687,"median":-9.917992,"eighty":-6.810664,"marketCap":183029728},{"date":"2026-08-14","current":-6.239509,"twenty":-17.454165,"median":-9.793252,"eighty":-6.730479,"marketCap":187286234},{"date":"2026-08-21","current":-4.207016,"twenty":-17.441707,"median":-9.728074,"eighty":-6.591693,"marketCap":189239834},{"date":"2026-08-28","current":-5.61745,"twenty":-17.34827,"median":-9.659831,"eighty":-6.31363,"marketCap":251065348},{"date":"2026-09-04","current":-5.551208,"twenty":-17.285978,"median":-9.555453,"eighty":-6.177212,"marketCap":249452508},{"date":"2026-09-11","current":-5.179874,"twenty":-17.261061,"median":-9.448244,"eighty":-6.142393,"marketCap":232248887},{"date":"2026-09-15","current":-5.301442,"twenty":-17.236144,"median":-9.427324,"eighty":-6.052626,"marketCap":236012179}],"updateTime":1789562242019},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGEN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133039688","title":"NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1133039688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133039688?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 19:16","pubTimestamp":1779794209,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布，其研究性药物Nvg-291在针对多发性硬化症患者的1B/2a期Connect Sci临床研究中，取得了具有统计学显著意义的步态质量改善。研究数据显示，与安慰剂组相比，接受Nvg-291治疗的患者在步态分析的关键指标上表现出显著提升。Nvg-291是一种旨在促进神经修复和功能恢复的新型疗法。公司表示，将继续推进相关临床开发计划，以进一步评估Nvg-291在更广泛神经系统适应症中的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637237354","title":"熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2637237354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637237354?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:29","pubTimestamp":1779395349,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4T41Y24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174712044","title":"NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1174712044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174712044?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393853,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp.宣布，公司已启动一项承销公开发行，将发行普通股、认股权证及预融资认股权证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102911496","title":"NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1102911496","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102911496?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393852,"startTime":"0","endTime":"0","summary":"NervGen Pharma 公司宣布，此次融资所得净收益将主要用于推进其核心候选药物Nvg-291的临床研究，并支持公司的一般运营与战略发展。此举旨在加速该疗法的开发进程，为未来的商业化奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGEN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NGEN\",params:#limit:6,delay:false,,,undefined,":[]}}